PDPN, podoplanin, 10630

N. diseases: 256; N. variants: 3
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Hereditary lymphedema and yellow nails
0.010 Biomarker disease BEFREE Immunohistochemistry was performed on archival sinonasal mucosal samples from 5 patients with YNS and 14 controls with antibodies against podoplanin and CD31, markers of lymphatics. 31589812 2020
CUI: C0267008
Disease: Erythroplakia of mouth
Erythroplakia of mouth
0.010 AlteredExpression disease BEFREE Strikingly, we observed that the expression of podoplanin and ABCG2 within a single pre-neoplastic OE lesion significantly correlate with subsequently developing multiple and multifocal carcinomas, thus to some extent demonstrating the concept of field cancerization. 31300272 2020
CUI: C0278996
Disease: Malignant Head and Neck Neoplasm
Malignant Head and Neck Neoplasm
0.010 Biomarker disease BEFREE Podoplanin and ABCG2 are promising marker of CSCs for head and neck cancer. 31300272 2020
CUI: C3887461
Disease: Head and Neck Carcinoma
Head and Neck Carcinoma
0.010 Biomarker disease BEFREE Podoplanin and ABCG2 are promising marker of CSCs for head and neck cancer. 31300272 2020
CUI: C0003504
Disease: Aortic Valve Insufficiency
Aortic Valve Insufficiency
0.010 AlteredExpression disease BEFREE We determined podoplanin expression in human aortic valves in four patient groups: control (C, n=7), aortic regurgitation (AR, n=8), aortic regurgitation and fibrosis (AR + f, n=15) and AS (n=49) by immunohistochemistry and quantitative real-time PCR (RT-PCR). 30616084 2019
CUI: C0003507
Disease: Aortic Valve Stenosis
Aortic Valve Stenosis
0.010 AlteredExpression disease BEFREE Podoplanin mRNA levels were 1.7-fold higher in the AS group as compared with the control group (P=.05). 30616084 2019
CUI: C0004779
Disease: Basal Cell Nevus Syndrome
Basal Cell Nevus Syndrome
0.010 AlteredExpression disease BEFREE Further, podoplanin expression was the highest in the suprabasal layer of NBCCS lesions, followed by the suprabasal layers of OK and OOC lesions. 31241560 2019
CUI: C0007114
Disease: Malignant neoplasm of skin
Malignant neoplasm of skin
0.010 AlteredExpression disease BEFREE The Prognostic Value of Podoplanin Expression in Nonmelanoma Skin Cancers: Correlation With Lymphatic Vessel Density. 31688008 2019
CUI: C0007118
Disease: Carcinoma, Basosquamous
Carcinoma, Basosquamous
0.010 AlteredExpression disease BEFREE The highest mean value of podoplanin expression (both intratumoral and peritumoral cells) was observed in SCC followed by BSC, then BCC, SK, and control skin in the same sequence. 31688008 2019
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.010 Biomarker disease BEFREE Podoplanin mediates the renoprotective effect of berberine on diabetic kidney disease in mice. 31270434 2019
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.010 AlteredExpression disease BEFREE Administration of berberine (100, 200 mg/kg every day, ig, for 8 weeks) significantly improved hyperglycemia and the renal function of STZ-induced diabetic mice and restored the expression level of podoplanin in renal glomerulus. 31270434 2019
CUI: C0022603
Disease: Seborrheic keratosis
Seborrheic keratosis
0.010 AlteredExpression disease BEFREE This work aimed at studying the immunohistochemical expression of podoplanin in nonmelanoma skin cancers (NMSCs) and seborrheic keratosis (SK) in comparison to normal control skin and to evaluate its possible role in their pathogenesis. 31688008 2019
CUI: C0029408
Disease: Degenerative polyarthritis
Degenerative polyarthritis
0.010 Biomarker disease BEFREE Conditional deletion of E11/podoplanin in bone protects against load-induced osteoarthritis. 31351471 2019
CUI: C0030305
Disease: Pancreatitis
Pancreatitis
0.010 Biomarker disease BEFREE Podoplanin (Th17 marker)-expressing lymphocytes were present in the lymphoid follicles of those with follicular pancreatitis, whereas these were absent in normal lymph nodes and in lymphoid follicles of those with IgG4-related autoimmune pancreatitis (AIP). 30515871 2019
CUI: C0031090
Disease: Periodontal Diseases
Periodontal Diseases
0.010 Biomarker group BEFREE Podoplanin expression is highly associated with an increased inflammatory infiltration suggesting that PDPN might play an additional role in periodontal disease, other than solely as a lymphangiogenesis marker. 30656679 2019
CUI: C0033999
Disease: Pterygium
Pterygium
0.010 AlteredExpression disease BEFREE Primary grade 2 pterygium (n=20) and normal conjunctiva (n=20) biopsies were obtained during surgery after written informed consent. mRNA expression for CD31, podoplanin, and VEGF (isoforms VEGF-A and VEGF-165) were determined by qRT-PCR. 30821336 2019
CUI: C0037286
Disease: Skin Neoplasms
Skin Neoplasms
0.010 Biomarker group BEFREE Podoplanin plays an evident role in the development and progression of both benign and malignant skin neoplasms and may serve as a potential predictor of their clinical course and prognosis. 31688008 2019
CUI: C0042373
Disease: Vascular Diseases
Vascular Diseases
0.010 Biomarker group BEFREE They did not differ in anthropometric or histomorphometric parameters [mesothelial coverage, submesothelial fibrosis, blood, and lymphatic vascularization, leukocyte, macrophage and activated fibroblast counts, epithelial-mesenchymal transition (EMT), podoplanin positivity and vasculopathy]. 31001140 2019
CUI: C0042769
Disease: Virus Diseases
Virus Diseases
0.010 Biomarker group BEFREE GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infection. 31309159 2019
CUI: C0149637
Disease: Lip Carcinoma
Lip Carcinoma
0.010 AlteredExpression disease BEFREE Podoplanin and CD44v6 were strongly expressed by tumor cells and podoplanin immunoexpression can help to determine lip cancer patients with lower risk for disease recurrence. 30770986 2019
CUI: C0153340
Disease: Cancer of Lip
Cancer of Lip
0.010 AlteredExpression disease BEFREE Podoplanin and CD44v6 were strongly expressed by tumor cells and podoplanin immunoexpression can help to determine lip cancer patients with lower risk for disease recurrence. 30770986 2019
CUI: C0153392
Disease: Malignant neoplasm of nasopharynx
Malignant neoplasm of nasopharynx
0.010 AlteredExpression disease BEFREE Endogenous PDPN expression in C8161 cells and nasopharyngeal cancer cell line CNE-2 was detected using western blot and flow cytometry. 31208371 2019
CUI: C0155626
Disease: Acute myocardial infarction
Acute myocardial infarction
0.010 Biomarker disease BEFREE Podoplanin neutralization improves cardiac remodeling and function after acute myocardial infarction. 31287805 2019
CUI: C0162565
Disease: Acute intermittent porphyria
Acute intermittent porphyria
0.010 Biomarker disease BEFREE Podoplanin (Th17 marker)-expressing lymphocytes were present in the lymphoid follicles of those with follicular pancreatitis, whereas these were absent in normal lymph nodes and in lymphoid follicles of those with IgG4-related autoimmune pancreatitis (AIP). 30515871 2019
CUI: C0206696
Disease: Carcinoma, Signet Ring Cell
Carcinoma, Signet Ring Cell
0.010 Biomarker disease BEFREE An observational retrospective study on 50 cases of SRC in stage II and III has been performed with the addition of histochemical (Alcian Blue, DDD-Fast Blue B, Mercury Orange) and immunohistochemical (cytocheratin, CD3, CD4, CD8, CD10, CD56, CD68, perforin, granzyme B, podoplanin, collagen type IV) investigations for each case. 30064231 2019